Loading provider…
- Featuresarrow_drop_down
- Resourcesarrow_drop_down
- Pricing
Loading provider…
Pediatric Hematology & Oncology Physician in Burlington, VT
NPI: 1760408009Primary Practice Location
—
111 Colchester Ave, Burlington, Vermont, 05401
HQ Phone
Get M.D. Alan's Phone NumberMobile
Get M.D. Alan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
VT State Medical License
UMass Chan Medical School
umassmed.edu
Residency • Pediatrics
1981 - 1982
Authors: Carl Nelson, Alissa Thomas, Suzanne Tucker, Susan Durham
Journal: Pediatr Blood Cancer
Publication Date: 2018-09-25
Authors: Natasha Frederick, John Denninger, Jeffrey Peppercorn, Annah Abrams, Lisa Kenney, Ghazala Usmani
Journal: JMIR Res Protoc
Publication Date: 2022-01-26
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer.
Authors: Susan Colace, Mark Applebaum, Margaret Macy, Junne Kamihara, Amit Sabnis, Luke Maese, Suzanne Forrest, Brian Crompton, Theodore Laetsch, Daniel Weiser, Julia Glade Bender
Journal: Nat Med
Publication Date: 2022-06-23
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI), EsPhALL
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, DRUG: Doxorubicin, DRUG: Dexamethasone, DRUG: Cyclophosphamide, DRUG: Cytarabine, DRUG: Ifosfamide, DRUG: Etoposide, DRUG: Vincristine Sulfate, DRUG: Methotrexate, DRUG: Methylprednisolone, BIOLOGICAL: Filgrastim, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation, DRUG: Mercaptopurine, DRUG: Calaspargase Pegol, DRUG: Prednisolone, DRUG: Imatinib Mesylate, DRUG: Therapeutic Hydrocortisone, DRUG: Thioguanine, DRUG: Pegaspargase, DRUG: Leucovorin Calcium, DRUG: Daunorubicin Hydrochloride, DRUG: Levoleucovorin, DRUG: Dexrazoxane Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, RADIATION: Radiation Therapy, DRUG: Cyclophosphamide, DRUG: Vincristine Sulfate, BIOLOGICAL: Dactinomycin, DRUG: Vinorelbine, DRUG: Temsirolimus, DRUG: Irinotecan Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, OTHER: Quality-of-Life Assessment, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Brentuximab Vedotin, DRUG: Etoposide, DRUG: Vincristine Sulfate, DRUG: Methylprednisolone, BIOLOGICAL: Bleomycin Sulfate, DRUG: Doxorubicin Hydrochloride